ArticleJCEM case reports2026

Preoperative Burosumab With Delayed FGF23 Recovery and High Postoperative Bone Turnover in Tumor-Induced Osteomalacia.

Heng Yeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.